Medicare Enrolled

Dr. Aimee Garza, MD

Neurology · Frisco, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
7000 PARKWOOD BLVD, Frisco, TX 75034
2144944424
In practice since 2007 (18 years)
NPI: 1487854667 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Garza from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Garza? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Garza

Dr. Aimee Garza is a neurology in Frisco, TX, with 18 years in practice. Based on federal Medicare data, Dr. Garza performed 283 Medicare services across 146 unique beneficiaries.

Between the years covered by Open Payments, Dr. Garza received a total of $181,880 from 116 pharmaceutical and/or device companies across 2232 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Garza is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ 283 Medicare services$ $181,880 industry payments

Medicare Practice Summary

Medicare Utilization ↗
283
Medicare services
Bottom 36% in TX for neurology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
146
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~16 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)211$80$221
Office visit, established patient, complex (40-54 min)31$105$221
Needle measurement of electrical activity in arm or leg muscles, complete study23$71$125
Office visit, established patient (20-29 min)18$40$221
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$181,880
Total received (2018-2024)
Avg $25,983/year across 7 years
Top 4% in TX for neurology
116
Companies
2,232
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$126,545 (69.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$31,069 (17.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$24,266 (13.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$13,270
2023
$10,880
2022
$53,607
2021
$34,039
2020
$28,837
2019
$19,559
2018
$21,687

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$51,574
ABBVIE INC.
$28,031
IMPEL PHARMACEUTICALS INC.
$17,525
Allergan, Inc.
$14,470
Promius Pharma LLC
$12,870
Novartis Pharmaceuticals Corporation
$6,376
Biohaven Pharmaceuticals, Inc.
$5,932
AbbVie Inc.
$5,079
Banner Life Sciences, LLC
$5,016
EMD Serono, Inc.
$3,118
Biohaven Pharmaceutical Holding Company Ltd.
$3,116
Biogen, Inc.
$2,693
LivaNova USA, Inc.
$1,818
UCB, Inc.
$1,436
Supernus Pharmaceuticals, Inc.
$1,238
GENZYME CORPORATION
$1,186
Amgen Inc.
$1,144
Genentech USA, Inc.
$1,019
Neurocrine Biosciences, Inc.
$970
Lilly USA, LLC
$862
PFIZER INC.
$809
Eisai Inc.
$712
SK Life Science, Inc.
$705
ACADIA Pharmaceuticals Inc
$646
Lundbeck LLC
$645
Allergan Inc.
$640
Avanir Pharmaceuticals, Inc.
$523
ARGENX US, INC.
$511
Grifols USA, LLC
$459
UPSHER-SMITH LABORATORIES LLC
$425
Alexion Pharmaceuticals, Inc.
$416
CSL Behring
$416
Acorda Therapeutics, Inc
$414
Upsher-Smith Laboratories LLC
$398
Celgene Corporation
$381
MITSUBISHI TANABE PHARMA AMERICA, INC.
$367
Janssen Pharmaceuticals, Inc
$351
AbbVie, Inc.
$351
EDW Pharma, Inc.
$343
Adamas Pharmaceuticals, Inc.
$338
Axsome Therapeutics, Inc.
$312
Amneal Pharmaceuticals LLC
$302
Abbott Laboratories
$268
MDD US Operations, LLC
$253
Alnylam Pharmaceuticals Inc.
$233
Kyowa Kirin, Inc.
$232
SCILEX PHARMACEUTICALS INC.
$231
JAZZ PHARMACEUTICALS INC.
$217
Neurelis, Inc.
$202
Merz Pharmaceuticals, LLC
$185
Assertio Therapeutics, Inc.
$183
Takeda Pharmaceuticals U.S.A., Inc.
$179
MERZ NORTH AMERICA, INC.
$173
Novo Nordisk Inc
$151
E.R. Squibb & Sons, L.L.C.
$141
EISAI INC.
$141
Sunovion Pharmaceuticals Inc.
$139
ASSERTIO THERAPEUTICS, Inc.
$136
US WorldMeds, LLC
$127
Penumbra, Inc.
$121
Mitsubishi Tanabe Pharma America, Inc.
$119
IDORSIA PHARMACEUTICALS US INC
$119
Corium, LLC
$104
Harmony Biosciences LLC
$95
Horizon Therapeutics plc
$94
Bausch Health US, LLC
$84
Aprecia Pharmaceuticals, LLC
$84
Tonix Medicines, Inc.
$83
Strongbridge US INC.
$77
ARBOR PHARMACEUTICALS, INC.
$72
AQUESTIVE THERAPEUTICS, INC.
$71
Mallinckrodt Enterprises LLC
$71
Xeris Pharmaceuticals, Inc.
$69
Ipsen Biopharmaceuticals, Inc
$65
CATALYST PHARMACEUTICALS, INC.
$63
Currax Pharmaceuticals LLC
$61
HARMONY BIOSCIENCES LLC
$60
Cycle Pharmaceuticals Inc
$59
Boston Scientific Corporation
$58
Otsuka America Pharmaceutical, Inc.
$57
Scilex Pharmaceuticals Inc.
$57
Collegium Pharmaceutical, Inc.
$57
Mallinckrodt Hospital Products Inc.
$56
Avion Pharmaceuticals
$54
Octapharma USA, Inc.
$46
Arbor Pharmaceuticals, Inc.
$44
Azurity Pharmaceuticals, Inc.
$43
Pernix Therapeutics Holdings, Inc.
$40
Impax Laboratories, Inc.
$40
TG Therapeutics, Inc.
$39
Jazz Pharmaceuticals Inc.
$36
AngioDynamics, Inc.
$35
Vertical Pharmaceuticals, LLC
$32
Almatica Pharma LLC
$30
Sandoz Inc.
$29
TerSera Therapeutics LLC
$28
Medtronic, Inc.
$28
Aucta Pharmaceuticals, Inc.
$27
Averitas Pharma Inc.
$27
Exeltis, USA Inc.
$26
BANNER LIFE SCIENCES, LLC
$25
NS Pharma, Inc.
$23
Alfasigma USA, Inc.
$22
Piramal Imaging Limited
$21
GE Healthcare
$21
REVANCE THERAPEUTICS, INC.
$21
Merck Sharp & Dohme Corporation
$19
AstraZeneca Pharmaceuticals LP
$19
Zyla Life Sciences
$18
Medtronic USA, Inc.
$18
Saol Therapeutics Inc.
$17
GE HealthCare
$17
Endo Pharmaceuticals Inc.
$15
Bayer HealthCare Pharmaceuticals Inc.
$14
Merz North America, Inc.
$12
BOSTON SCIENTIFIC CORPORATION
$11
Top 3 companies account for 53.4% of total payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA PC · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · Axium INS DRG IPG · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · COMIRNATY · CONFIRM RX · COPAXONE · Cambia · Cenobamate · Confirm Rx · DAXXIFY · DAYBUE · DUEXIS · DUOPA · DYSPORT · Dayvigo · Dhivy · Duopa · Dysport · ELYXYB - CELECOXIB · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Enspryng · FIRDAPSE · Fycompa · GAMMAGARD · GENERAL - DBS · GILENYA · GOCOVRI · GRALISE · GVOKE PFS · Gamunex-C · Gocovri · Gralise · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INTELLIS ADAPTIVESTIM · JARDIANCE · KESIMPTA · KEVEYIS · LEMTRADA · LORZONE · LYRICA · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · Motpoly XR · NAPRELAN · NASCOBAL · NEURACEQ · NEXVIAZYME · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Neuromodulation Dspsbls and Accs · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · ONZETRA XSAIL · OSMOLEX ER · OXTELLAR XR · Ongentys · Ozempic · PANZYGA · PAXLOVID · PLEGRIDY · PURIFIED CORTROPHIN GEL · Penumbra System · Ponvory · Privigen · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · QUVIVIQ · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SILENOR · SKYCLARYS · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · SYMPAZAN · Soliris · Spritam · Sunosi · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Tascenso ODT · Tiglutik · Tosymra Sumatriptan Nasal Spray · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VECTRIS · VERCISE · VILTEPSO · VIMOVO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · WAKIX · Wakix · XARELTO · XCOPRI · XEOMIN · Xadago · Xembify · Xeomin · Xermelo · ZEMBRACE SYMTOUCH · ZEPOSIA · ZIPSOR · ZOHYDRO ER · ZOMIG · ZTLido · Zembrace · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (70%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for neurology in TX.

Equivalent to $64,268 per 100 Medicare services performed
Looking for a neurology in Frisco?
Compare neurologys in the Frisco area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
217
Per 100K population
19.4
County median income
$117,588
Nearest hospital
BAYLOR SCOTT & WHITE MEDICAL CENTER - FRISCO
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Garza is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 4%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Garza experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Garza performed 211 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Garza receive payments from pharmaceutical companies?
Yes. Dr. Garza received a total of $181,880 from 116 companies across 2,232 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Garza's costs compare to other neurologys in Frisco?
Dr. Garza's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Garza) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →